Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 16584 - suture, polydioxanone - synthetic long-term absorbable monofilament, degradation by hydrolysis within 180-210 days. for use in general soft tissue approximation, specially in cases where an extended wound support of more than 4 weeks is desirable, paediatric cardiovascular surgery and for the suturing of autologous peripheral vessels. violet long-term absorbable synthetic monofilament suture made of polydioxanone. for use in orthopaedics (tendons, joint capsule), paediatric cardiovascular surgery, general surgery and abdominal wall closure.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 47406 - negative-pressure wound therapy system foam dressing - negative pressure wound therapy system dressing indicated for treatment of anastomotic leak in the low rectal area. also indicated in case of local peritonitis in the lower pelvic area, a local abscess that can be fully drained,local inflammation reactions in the lower pelvic area and for anastomotic insufficiencies following colo-rectal surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 13906 - suture, polyester - premicron is a non?absorbable braided and coated synthetic multifilament composed of polyester fibres.premicron sutures are coated uniformly with silicone to increase surface lubricity, thereby enhancing handling characteristics. a non-absorbable, coated suture indicated for use in general surgery, cardiovascular, and vascular indications.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 17246 - suture, polyglyconate - undyed short-term absorbable synthetic monofilament suture made of glyconate for the approximation of soft tissue with a fast healing process. monosyn quick is recommended for all soft tissue with a fast healing approximation. monosyn? quick is used for the adaptation of soft tissues and mucous membranes, when wound support over a period of 7 days is considered adequate. the main indications are dermal sutures, particularly in paediatric surgery; episiotomy (gynaecology); circumcision (urology).

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 17245 - suture, polybutester - monomax is an extra long-term absorbable monofilament synthetic suture made of poly-4 hydroxybutyrate. monomax degrades by hydrolysis and enzymatic reaction and provides a predictable and reliable longterm absorption. it sustains 50 % of its original strength for more than 3 months and can provide sufficient wound support during the healing process of the abdominal wall. monomax is intended for use in general soft tissue approximation, especially when the use of an absorbable monofilament suture with an extended wound support up to 15 weeks indicated. a typical indication is the abdominal wall closure after midline incision using a continuous, all layer suture technique.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 46930 - bone wax, natural - used for mechanical haemostasis in bone injuries

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 13910 - silk suture, sterile - silk suture for use in general surgery, skin closure, oral surgery, ophthalmic surgery and /or ligation in general practices.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 47406 - negative-pressure wound therapy system foam dressing - ? treatment of anastomotic leaks or perforations in the upper gastrointestinal tract* by means of negative pressure including intraluminal or intracavitary therapy of paraoesophageal and mediastinal septic focus or localised abscesses endoscopically accessible. ? preventive therapy to reduce the risk of anastomotic leaks in the upper gastrointestinal tract*. *the upper gastrointestinal tract refers to the oesophagus, stomach and duodenum, endoscopically accessible within the range of the overtube length.

Australia - English - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - 47406 - negative-pressure wound therapy system foam dressing - treatment of complex anal fistulas by means of negative pressure.